Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Gryrotonic Training in Behcet-diseased Elders With Breast Cancer

5. november 2026 oppdatert av: Ali Mohamed Ali ismail, Cairo University

gryrotonic training may be a good exercise modality in Behcet-diseased elders with breast cancer

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

forty Behcet-diseased elders with breast cancer will randomy divide into group I (receive gyrotonic exercise three session weekly for 12 week) or group II (wait list)

Studietype

Intervensjonell

Registrering (Antatt)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

  • Egypt
    • Dokki
      • Giza, Dokki, Egypt
        • Rekruttering
        • Cairo University
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

65 år til 75 år (Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • beast cancer survivors
  • behcet diseas patients

Exclusion Criteria:

  • cardiac or repiratory or renal failure patients

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: group number 1

twenty Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will 45 min
Atferdsmessig: exercise

twnety Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will last for 45 min
Ingen inngripen: group number 2

twenty Behcet-diseased elders who survivied from breast cancer will be wait list for 12 weeks

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Short Physical Performance Battery
Tidsramme: it will be measured after 12 weeks

the total score will be calcualted
it will be measured after 12 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Dual task gait speed
Tidsramme: It will be measured after 12 weeks

this task assess gait speed
It will be measured after 12 weeks
Four-square step test
Tidsramme: It will be measured after 12 weeks

it is fucntional balnce test
It will be measured after 12 weeks
grip strenghts
Tidsramme: It will be measured after 12 weeks

it is a measure of grip strenghths in dominant hand
It will be measured after 12 weeks
time up- and go testing
Tidsramme: It will be measured after 12 weeks

it is a measure of fall risk
It will be measured after 12 weeks
sit-to-stand 30-second testing
Tidsramme: It will be measured after 12 weeks

asess number of repteations of sit-to-staning in 30 seconds
It will be measured after 12 weeks
six minute walking testingg
Tidsramme: It will be measured after 12 weeks

distance covered by subject in six minutes wil be assessed
It will be measured after 12 weeks
10-meters walking testing
Tidsramme: It will be measured after 12 weeks

time covered for walking for ten meter will be assessed
It will be measured after 12 weeks
trunk-flexor McGill core endurance test
Tidsramme: It will be measured after 12 weeks

this test will assess endurance of trunk flexors
It will be measured after 12 weeks
trunk-extensor McGill core endurance test
Tidsramme: It will be measured after 12 weeks

this test will assess endurance of trunk extensors
It will be measured after 12 weeks
right-lateral-trunk-bending McGill core endurance test
Tidsramme: It will be measured after 12 weeks

this test will assess endurance of right lateral trunk bendors
It will be measured after 12 weeks
left-lateral-trunk-bending McGill core endurance test
Tidsramme: It will be measured after 12 weeks

this test will assess endurance of left lateral trunk bendors
It will be measured after 12 weeks
arm flexion in thrity seconds
Tidsramme: It will be measured after 12 weeks

it will assess numbers (repeations) of arm flexion in thirty second
It will be measured after 12 weeks
maximal nubmer of push up
Tidsramme: It will be measured after 12 weeks

this will assess maximal number of performed psh ups in speciifc time
It will be measured after 12 weeks
behcet disease quality of life
Tidsramme: It will be measured after 12 weeks

questioanire that will assess life quality in behcet disease (total score will be estiamted)
It will be measured after 12 weeks
total score of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess quality of life
It will be measured after 12 weeks
physical fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess physical fucntion related quality of life
It will be measured after 12 weeks
role fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess role fucntion related quality of life
It will be measured after 12 weeks
emotional fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess emotional fucntion related quality of life
It will be measured after 12 weeks
cognitive fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess cognitive fucntion related quality of life
It will be measured after 12 weeks
social fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess social fucntion related quality of life
It will be measured after 12 weeks
fatigue fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess fatigue
It will be measured after 12 weeks
nausea-vomiting subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it is a questioaire asess nausea-vomiting
It will be measured after 12 weeks
pain subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess pain
It will be measured after 12 weeks
dyspnea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess dyspnea
It will be measured after 12 weeks
insomnia subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess insomnia
It will be measured after 12 weeks
appetite-loss subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess appetite loss
It will be measured after 12 weeks
constipation subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess constipation
It will be measured after 12 weeks
diarrhea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess diarrhea
It will be measured after 12 weeks
financial difficulties subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Tidsramme: It will be measured after 12 weeks

it will assess financial difficulties
It will be measured after 12 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Cairo University

Etterforskere

  • Hovedetterforsker: Ali MA Ismail, phd, Cairo University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

30. november 2026

Primær fullføring (Antatt)

30. mai 2027

Studiet fullført (Antatt)

30. mai 2027

Datoer for studieregistrering

Først innsendt

5. november 2026

Først innsendt som oppfylte QC-kriteriene

5. november 2026

Først lagt ut (Faktiske)

10. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

5. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • IRB00014233-118

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere